Evidence map›Paper›PMID 38902223›Full record

ArticleNature communications2024

Plasma cell differentiation is regulated by the expression of histone variant H3.3.

Yuichi Saito, Akihito Harada, Miho Ushijima, Kaori Tanaka, Ryota Higuchi, Akemi Baba, Daisuke Murakami, Stephen L Nutt, Takashi Nakagawa, Yasuyuki Ohkawa and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuichi SaitoDivision of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Akihito HaradaDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Miho UshijimaDivision of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Kaori TanakaDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Ryota HiguchiDivision of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.ORCID http://orcid.org/0009-0001-8181-8941
Akemi BabaDivision of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Daisuke MurakamiDepartment of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID http://orcid.org/0000-0002-8794-9141
Stephen L NuttThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3050, Australia.ORCID http://orcid.org/0000-0002-0020-6637
Takashi NakagawaDepartment of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID http://orcid.org/0000-0002-3198-639X
Yasuyuki OhkawaDivision of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. yohkawa@bioreg.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0001-6440-9954
Yoshihiro BabaDivision of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. babay@bioreg.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0001-7753-0905

Funding

Japan Agency for Medical Research and Development (AMED) JP19ek0410044Japan Agency for Medical Research and Development (AMED) JP19gm6110004Japan Agency for Medical Research and Development (AMED) JP22ama121017j0001Japan Agency for Medical Research and Development (AMED) JP23gm1810008MEXT | Japan Society for the Promotion of Science (JSPS) JP18H02626MEXT | Japan Society for the Promotion of Science (JSPS) JP18H05527MEXT | Japan Society for the Promotion of Science (JSPS) JP19K22537MEXT | Japan Society for the Promotion of Science (JSPS) JP20H00456MEXT | Japan Society for the Promotion of Science (JSPS) JP20H05368MEXT | Japan Society for the Promotion of Science (JSPS) JP21H02753MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05292MEXT | Japan Society for the Promotion of Science (JSPS) JP22H04676MEXT | JST | Precursory Research for Embryonic Science and Technology (PRESTO) JPMJPR19K7
6 · The paper itself

Abstract

The differentiation of B cells into plasma cells is associated with substantial transcriptional and epigenetic remodeling. H3.3 histone variant marks active chromatin via replication-independent nucleosome assembly. However, its role in plasma cell development remains elusive. Herein, we show that during plasma cell differentiation, H3.3 is downregulated, and the deposition of H3.3 and chromatin accessibility are dynamically changed. Blockade of H3.3 downregulation by enforced H3.3 expression impairs plasma cell differentiation in an H3.3-specific sequence-dependent manner. Mechanistically, enforced H3.3 expression inhibits the upregulation of plasma cell-associated genes such as Irf4, Prdm1, and Xbp1 and maintains the expression of B cell-associated genes, Pax5, Bach2, and Bcl6. Concomitantly, sustained H3.3 expression prevents the structure of chromatin accessibility characteristic for plasma cells. Our findings suggest that appropriate H3.3 expression and deposition control plasma cell differentiation.

Indexed as

Cell DifferentiationHistonesPlasma CellsAnimalsB-LymphocytesChromatinGene Expression RegulationHumansInterferon Regulatory Factor-4Interferon Regulatory FactorsMiceMice, Inbred C57BLChromatinHistonesInterferon Regulatory Factor-4Interferon Regulatory Factors

Identifiers

PMID38902223
PMCPMC11190180

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.